Posted in Antibodies , Assay Kits , Biology Cells , cDNA , Clia Kits , Culture Cells , Devices , DNA , DNA Templates , DNA Testing , Elisa Kits , Enzymes , Equipments , Exosomes , Gels , Isotypes , Medium & Serums , NATtrol , Panel , Particles , PCR , Pcr Kits , Peptides , Reagents , Recombinant Proteins , Ria Kits , RNA , Test Kits , Vector & Virus , Western Blot
Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? – Literature review
Introduction: Multiple myeloma is a hematologic disease that is progressive and incurable characterized by irregular and clonal multiplication plasmacytes in the bone marrow. The main clinical manifestations caused by the presence of neoplastic cells in the bone tissue, and excessive production of immunoglobulins and humoral immune suppression normal. Daratumumab is an anti-CD38 monoclonal antibody that promise results in managing the disease multiple myeloma.
Objective: This study aimed to determine the scientific evidence regarding the impact of cytomegalovirus infection in treatment programs daratumumab in multiple myeloma patients extensively pre-treatment.
Methods: For this purpose, an integrative literature review conducted on a different database, which consists of a period of 5 years.
Results: The study analysis revealed that the reactivation of cytomegalovirus infection may occur during the use of daratumumab in previously treated multiple myeloma patients, which led to discontinuation of treatment, compromised drug efficacy and disease progression favored. In addition, it was observed that even with prophylactic antiviral therapy there is a reactivation of infection in some cases, and death, in a more serious situation.
Conclusion : So, even considering some of the reports on these topics is available in the scientific literature, this review suggests that cytomegalovirus reactivation can interfere daratumumab therapy, especially in heavily pretreated multiple myeloma patients. In addition, this research can contribute as a tool for clinical decisions and management of adverse events in medical practice, demonstrating the importance of monitoring patients for the possibility of cytomegalovirus reactivation in patients with heavily pretreated myeloma.
Do cytomegalovirus infections affect the daratumumab treatment course in multiple myeloma patients? – Literature review
Comparison of different cytomegalovirus disease following haploidentical hematopoietic stem cell transplantation
Cytomegalovirus (CMV) can cause end-organ disease including pneumonia, gastroenteritis, retinitis, and encephalitis in hematopoietic stem cell transplant recipients. the potential difference between the different CMV disease remains uncertain.
This study aimed to compare the clinical characteristics, risk factors, and mortality among the different CMV disease. A retrospective case-control study carried out based on a cohort of 3862 patients undergoing haploidentical hematopoietic stem cell transplantation in a single-center. CMV disease occurred in 113 (2.92%) of 3,862 haplo-HSCT recipients, including the possibility of CMV pneumonia (CMVP, n = 34), proved to CMV gastroenteritis (CMVG, n = 34), CMV retinitis (CMVR, n = 31) , the possibility of CMV encephalitis (CMVE, n = 7), and disseminated CMV disease (Di-CMVD, n = 7). Most (91.2%) cases CMVG developed in 100 days, while the majority (90.3%) cases of late-onset CMVR.
Lenti-CDK4 Virus
LV611
ABM
10 ml
EUR 973.2
Lenti-hTERT virus
G200
ABM
10 ml
EUR 973.2
Rev-CEM-Luc HIV Reporter Cells
HRC-6
101Bio
-
Ask for price
AAV2-Luc Control Virus
AAV-320
Cell Biolabs
50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 2.
AAV1-Luc Control Virus
AAV-321
Cell Biolabs
50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 1.
AAV3-Luc Control Virus
AAV-323
Cell Biolabs
50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 3.
AAV4-Luc Control Virus
AAV-324
Cell Biolabs
50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 4.
AAV5-Luc Control Virus
AAV-325
Cell Biolabs
50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 5.
AAV6-Luc Control Virus
AAV-326
Cell Biolabs
50 ?L
EUR 1221.6
Description: Luciferase control virus of AAV serotype 6.
Rev-A3R5-GFP/Luc HIV Reporter Cells
HRC-2
101Bio
-
Ask for price
Rev-CEM-GFP/Luc HIV Reporter Cells
HRC-5
101Bio
-
Ask for price
Lenti-hTERT Antisense virus
G201
ABM
10 ml
EUR 882
Lenti-hTERT-Neo Virus
G204
ABM
10 ml
EUR 973.2
Lenti-Myc T58A Virus
G217
ABM
10 ml
EUR 973.2
Lenti-p53 siRNA Virus
G219
ABM
10 ml
EUR 973.2
Lenti-Ras V12 Virus
G221
ABM
10 ml
EUR 973.2
Lenti-Rb siRNA Virus
G223
ABM
10 ml
EUR 973.2
Lenti-Bmi1 Virus, High Titer
LV608
ABM
5 x 20 ul
EUR 1825.2
Lenti-CDK4 Virus, High Titer
LV609
ABM
5 x 20 ul
EUR 1825.2
Lenti-hTERT Virus, High Titer
LV615
ABM
5 x 20 ul
EUR 1825.2
Lenti-EF1α-hTERT Virus
G706
ABM
10 ml
EUR 1094.4
Steady-Luc Firefly HTS Assay Kit (10x100 ml)
30028-3
Biotium
1KIT
EUR 3774
Description: Minimum order quantity: 1 unit of 1KIT
Human BM88 Differentiation Reporter (pGreenZeo, Virus)
SR10021VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse Camk2a Differentiation Reporter (pGreenZeo, Virus)
SR10022VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse GAD67 Differentiation Reporter (pGreenZeo, Virus)
SR10023VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Rat NSE Differentiation Reporter (pGreenZeo, Virus)
SR10024VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse MBP Differentiation Reporter (pGreenZeo, Virus)
SR10026VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Opsin Differentiation Reporter (pGreenZeo, Virus)
SR10027VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Insulin Differentiation Reporter (pGreenZeo, Virus)
SR10028VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human LCK Differentiation Reporter (pGreenZeo, Virus)
SR10032VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Rat Nestin Differentiation Reporter (pGreenZeo, Virus)
SR10034VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Nestin Differentiation Reporter (pGreenZeo, Virus)
SR10035VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse ALBP Differentiation Reporter (pGreenZeo, Virus)
SR10036VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human NGN3 Differentiation Reporter (pGreenZeo, Virus)
SR10037VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human PDX1 Differentiation Reporter (pGreenZeo, Virus)
SR10039VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Osteocalcin Differentiation Reporter (pGreenZeo, Virus)
SR1003VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse PDX1 Differentiation Reporter (pGreenZeo, Virus)
SR10040VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human MAP2 Differentiation Reporter (pGreenZeo, Virus)
SR10047VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human FABP7 Differentiation Reporter (pGreenZeo, Virus)
SR10048VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human ACTC Differentiation Reporter (pGreenZeo, Virus)
SR10049VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human B29 Differentiation Reporter (pGreenZeo, Virus)
SR1004VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse Myogenin Differentiation Reporter (pGreenZeo, Virus)
SR10050VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human GFAP Differentiation Reporter (pRedZeo, Virus)
SR10051VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse B29 Differentiation Reporter (pGreenZeo, Virus)
SR1005VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human NKX2.5 Differentiation Reporter (pGreenZeo, virus)
SR10067VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse CD8 Differentiation Reporter (pGreenZeo, Virus)
SR1006VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse CD68 Differentiation Reporter (pGreenZeo, Virus)
SR1008VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human CD2 Differentiation Reporter (pGreenZeo, Virus)
SR1009VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Oct4 CR4-pGreenFire Response Reporter (virus)
SR20070-VA-1
SBI
>2 x 10^6 IFUs
EUR 882
Mouse Actc Differentiation Reporter (pGreenZeo, Virus)
SR10010VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Tnnt2 Differentiation Reporter (pGreenZeo, Virus)
SR10012VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse Tnnt2 Differentiation Reporter (pGreenZeo, Virus)
SR10013VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse SM22a Differentiation Reporter (pGreenZeo, Virus)
SR10014VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human GFAP Differentiation Reporter (pGreenZeo, Virus)
SR10015VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse GFAP Differentiation Reporter (pGreenZeo, Virus)
SR10016VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human CD11b Differentiation Reporter (pGreenZeo, Virus)
SR10017VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse EMR1 Differentiation Reporter (pGreenZeo, Virus)
SR10018VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse Col2a1 Differentiation Reporter (pGreenZeo, Virus)
SR1001VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Mouse CD44 Differentiation Reporter (pGreenZeo, Virus)
SR10020VA-1
SBI
>2 x 10^6 IFUs
EUR 906
NF-kB/293/GFP-Luc Transcriptional Reporter Cell Line
TR860A-1
SBI
>2 x 10^6 cells
EUR 3915.6
Lenti-Myc T58A Virus, High Titer
LV618
ABM
5 x 20 ul
EUR 1825.2
Lenti-p53 siRNA Virus, High Titer
LV619
ABM
5 x 20 ul
EUR 1825.2
Lenti-Ras V12 Virus, High Titer
LV620
ABM
5 x 20 ul
EUR 1825.2
Lenti-Rb siRNA Virus, High Titer
LV621
ABM
5 x 20 ul
EUR 1825.2
Lenti-hTERT-Neo Virus, High Titer
LV622
ABM
5 x 20 ul
EUR 1825.2
Lenti-EF1α-hTERT-Hygro Virus
LV631
ABM
10 ml
EUR 1270.8
Lenti-HPV-16 E6/E7 Virus
G268
ABM
10 ml
EUR 882
A2LD1 3'UTR Luciferase Stable Cell Line
TU000004
ABM
1.0 ml
EUR 1672.8
A2ld1 3'UTR Luciferase Stable Cell Line
TU200006
ABM
1.0 ml
Ask for price
A2ld1 3'UTR GFP Stable Cell Line
TU250006
ABM
1.0 ml
Ask for price
A2ld1 3'UTR GFP Stable Cell Line
TU151049
ABM
1.0 ml
Ask for price
A2ld1 3'UTR Luciferase Stable Cell Line
TU101049
ABM
1.0 ml
Ask for price
A2LD1 3'UTR GFP Stable Cell Line
TU050004
ABM
1.0 ml
EUR 1672.8
A2LD1 Antibody
39425-100ul
SAB
100ul
EUR 468
A2LD1 Antibody
39426-100ul
SAB
100ul
EUR 468
Mouse Alpha-Tubulin Differentiation Reporter (pGreenZeo, Virus)
SR10025VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human SPP-1 Differentiation Reporter (pGreenZeo, Virus)
SR1002VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Keratin 14 Differentiation Reporter (pGreenZeo, Virus)
SR10038VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human Doublecortin (DCX) Differentiation Reporter (pGreenZeo, Virus)
SR10041VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human HLA-DRa Differentiation Reporter (pGreenZeo, Virus)
SR1007VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human MLC-2v Differentiation Reporter (pGreenZeo, Virus)
SR10011VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Human GFAP Differentiation Reporter (pGreenZeo, Virus) Puro
SR10015VA-P
SBI
>2 x 10^6 IFUs
EUR 906
Mouse IBA-1 Differentiation Reporter (pGreenZeo, Virus)
SR10019VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Lenti-EF1α-hTERT Virus, High Titer
LV616
ABM
5 x 20 ul
EUR 2068.8
Lenti-CMV-hTERT-GFP-2A-Puro Virus
LV623
ABM
10 ml
EUR 1270.8
Lenti-CMV-hTERT-RFP-2A-Puro Virus
LV625
ABM
10 ml
EUR 1270.8
Human E-Cadherin, CDH1 Differentiation Reporter (pGreenZeo, virus)
SR10070VA-1
SBI
>2 x 10^6 IFUs
EUR 906
Sox2 SRR2-pGreenFire Response Reporter, pre-packaged virus
SR20071-VA-1
SBI
>2 x 10^6 IFUs
EUR 882
A2LD1 cloning plasmid
CSB-CL883610HU-10ug
Cusabio
10ug
EUR 285.6
Description: A cloning plasmid for the A2LD1 gene.
anti- A2LD1 antibody
FNab00013
FN Test
100µg
EUR 658.5
Description: Antibody raised against A2LD1
pLL-CMV-GFP-T2A-Puro [Lenti-LabelerTM virus]
LL100VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-GFP-T2A-Blast [Lenti-LabelerTM virus]
LL105VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-RFP-T2A-Puro [Lenti-LabelerTM virus]
LL110VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-RFP-T2A-Blast [Lenti-LabelerTM virus]
LL115VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-BFP-T2A-Puro [Lenti-LabelerTM virus]
LL120VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-BFP-T2A-Blast [Lenti-LabelerTM virus]
LL125VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-Luciferase-T2A-Puro [Lenti-LabelerTM virus]
LL150VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-GFP-T2A-Puro [Lenti-LabelerTM virus]
LL200VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-GFP-T2A-Blast [Lenti-LabelerTM virus]
LL205VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-RFP-T2A-Puro [Lenti-LabelerTM virus]
LL210VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-RFP-T2A-Blast [Lenti-LabelerTM virus]
LL215VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-BFP-T2A-Puro [Lenti-LabelerTM virus]
LL220VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-BFP-T2A-Blast [Lenti-LabelerTM virus]
LL225VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-EF1a-Luciferase-T2A-Puro [Lenti-LabelerTM virus]
LL250VA-1
SBI
>2x10^6 IFUs
EUR 810
pLL-CMV-rFLuc-T2A-GFP [Lenti-LabelerTM virus]
LL300VA-1
SBI
>2x10^6 IFUs
EUR 836.4
Lenti-HPV-16 E6/E7 Virus, High Titer
LV617
ABM
5 x 20 ul
EUR 1704
Human Alpha-Actin 2, ACTA2 Differentiation Reporter (pGreenZeo, virus)
SR10068VA-1
SBI
>2 x 10^6 IFUs
EUR 906
A2LD1 protein (His tag)
80R-1717
Fitzgerald
50 ug
EUR 476.4
Description: Purified recombinant Human A2LD1 protein
A2LD1 Recombinant Protein (Human)
RP000007
ABM
100 ug
Ask for price
A2LD1 Recombinant Protein (Mouse)
RP112952
ABM
100 ug
Ask for price
A2LD1 Recombinant Protein (Rat)
RP188432
ABM
100 ug
Ask for price
Lenti-CMV-hTERT-GFP-2A-Puro Virus, High Titer
LV624
ABM
5 x 20 ul
EUR 2191.2
Lenti-CMV-hTERT-RFP-2A-Puro Virus, High Titer
LV626
ABM
5 x 20 ul
EUR 2191.2
Lenti-EF1?¡À-hTERT-Hygro Virus, High Titer
LV632
ABM
5 x 20 ul
EUR 2191.2
Pooled Virus Library of all Lenti-miR microRNA Precursor Constructs [4 virus aliquots]
PMIRHPLVA-1
SBI
4 virus aliquots
EUR 5974.8
Lentiviral Dual Reporter: CMV-GFP-T2A-Luciferase pre-packaged virus
BLIV101VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
Lentiviral Triple Reporter: CMV-Luciferase-RFP-TK pre-packaged virus
BLIV102VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
Lentiviral Dual Reporter: UBC-RFP-T2A-Luciferase pre-packaged virus
BLIV200VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
Lentiviral Triple Reporter: UBC-Luciferase-RFP-TK pre-packaged virus
BLIV202VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
Lentiviral Triple Reporter: MSCV-Luciferase-RFP-TK pre-packaged virus
BLIV302VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
BLIV 2.0 Reporter: CMV-Luciferase-EF1a-copGFP Pre-packaged Virus
BLIV511VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
Human MLC-2v Differentiation Reporter (pGreenZeo, Virus), EF1-Neo Marker
SR10011VA-N
SBI
>2 x 10^6 IFUs
EUR 906
A2ld1 sgRNA CRISPR Lentivector (Mouse) (Target 3)
K4697504
ABM
1.0 ug DNA
EUR 184.8
A2LD1 sgRNA CRISPR Lentivector (Human) (Target 3)
K0013604
ABM
1.0 ug DNA
EUR 184.8
A2ld1 sgRNA CRISPR Lentivector (Rat) (Target 3)
K7213404
ABM
1.0 ug DNA
EUR 184.8
SKOV-3/Luc Cell Line
AKR-232
Cell Biolabs
1 vial
EUR 686.4
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line.
pLL-CMV-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus]
LL310VA-1
SBI
>2x10^6 IFUs
EUR 836.4
pLL-CMV-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus]
LL320VA-1
SBI
>2x10^6 IFUs
EUR 836.4
pLL-EF1a-rFLuc-T2A-GFP-mPGK-Puro [Lenti-LabelerTM virus]
LL410VA-1
SBI
>2x10^6 IFUs
EUR 836.4
pLL-EF1a-rFLuc-T2A-mRFP-mPGK-Puro [Lenti-LabelerTM virus]
LL420VA-1
SBI
>2x10^6 IFUs
EUR 836.4
Sox2 SRR2-pGreenFire Response Reporter (pre-packaged virus, EF1-Puro marker)
SR20071-VA-P
SBI
>2 x 10^6 IFUs
EUR 882
A2ld1 ORF Vector (Rat) (pORF)
ORF062812
ABM
1.0 ug DNA
EUR 607.2
A2LD1 ORF Vector (Human) (pORF)
ORF000003
ABM
1.0 ug DNA
EUR 114
A2ld1 ORF Vector (Mouse) (pORF)
ORF037652
ABM
1.0 ug DNA
EUR 607.2
pGL3 3'UTR reporter WT 1.3 kb CD274 Hs 3'UTR Final Plasmid
PVT17094
Lifescience Market
2 ug
EUR 390
BLIV 2.0 Reporter: MSCV-Luciferase-EF1a-copGFP-T2A-Puro Pre-packaged Virus
BLIV713VA-1
SBI
>2 x10^6 IFUs
EUR 963.6
pGreenFire 2.0 NFAT reporter virus (pGF2-NFAT-rFluc-T2A-GFP-mPGK-Puro)
TR451VA-P
SBI
>2 x 10^6 IFUs
EUR 920.4
β-Lactamase (Luciferase) lentiviral particles
LVP335-luc
GenTarget
1x107 IFU/ml x 200ul
EUR 418.8
Description: pre-made lentiviral particles expressing β-Lactamase gene. A firefly luciferase marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene.
A549 / Luciferase (Puromycin) stable cell line
SC043-Luc
GenTarget
2 x 106 cell/ml x 1ml
EUR 1104
Description: Luciferase (firefry) expression stable cell line in A549 human cancer cell line with Puromycin marker.
Human AsPC1 / Luciferase Cell Line
SC062-Luc
GenTarget
2 x 106 cell/ml x 1ml
EUR 1800
Description: Firefly luciferase expression stable cell line in Human AsPC1 cells with Puromycin resistance
mouse MOPC315 / Luciferase Cell Line
SC063-Luc
GenTarget
2 x 106 cell/ml x 1ml
EUR 2670
Description: Firefly luciferase expression stable cell line in mouse MOPC315 cells with Puromycin resistance
Huamn SW403 / Luciferase Stable Cells
SC067-Luc
GenTarget
2 x 106 cell/ml x 1ml
EUR 1800
Description: Firefly luciferase expression stable cell line in human SW403 cells with Puromycin resistance
Human PANC-1 / Luciferase (Puro) Cell Line
SC068-Luc
GenTarget
2 x 106 cell/ml x 1ml
EUR 2670
Description: Firefly luciferase expression stable cell line in Human PANC-1 cells with Puromycin resistance
A2ld1 sgRNA CRISPR Lentivector set (Mouse)
K4697501
ABM
3 x 1.0 ug
EUR 406.8
Bovine Gamma- glutamylaminecyclotransferase, A2LD1 ELISA KIT
ELI-49723b
Lifescience Market
96 Tests
EUR 1113.6
A2LD1 sgRNA CRISPR Lentivector set (Human)
K0013601
ABM
3 x 1.0 ug
EUR 406.8
Human Gamma- glutamylaminecyclotransferase, A2LD1 ELISA KIT
ELI-24712h
Lifescience Market
96 Tests
EUR 988.8
Mouse Gamma- glutamylaminecyclotransferase, A2ld1 ELISA KIT
ELI-24713m
Lifescience Market
96 Tests
EUR 1038
A2ld1 sgRNA CRISPR Lentivector set (Rat)
K7213401
ABM
3 x 1.0 ug
EUR 406.8
Lenti-SV40 Lentivirus
G203
ABM
10 ml
EUR 973.2
Lenti-SV40T Lentivirus
G256
ABM
10 ml
EUR 882
Lenti-SV40Tt Lentivirus
G258
ABM
10 ml
EUR 882
Fire-resistant CMV infection and CMV viral load at different levels associated with an increased risk of CMVP, CMVG, and CMVR. Compared with patients without CMV disease, significantly higher non-relapse mortality at 1 year after transplantation was observed in patients with CMVP and CMVR not CMVG. Patients with CMVP, In-CMVD, and CMVE have an overall mortality rate higher after diagnosis than patients with CMVG and CMVR (61.7%, 57.1%, 40.0% vs 27.7%, 18.6% , P = 0.001). In conclusion, time of onset, the viral dynamics, and different mortality between different CMV disease. CMV disease mortality remains high, especially for the CMVP, In-CMVD, and CMVE.